Predictors of acne scar development, methods of prevention and treatment


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Acne scars develop in 30-40% of patients and require active therapy, as they significantly reduce the quality of life of patients, affect self-esteem and social adaptation. The mechanism of the occurrence of acne scars is caused by a deep inflammatory process (or mechanical damage, as, for example, with excoriated acne), when destructive and then reparative changes in the dermal layers occur in response to inflammation, the outcome of which can be both atrophic scars and hypertrophic ones (less frequently keloid), which is determined by the reactivity of the dermal matrix. Despite the availability of effective drugs for the treatment of acne, their effectiveness in relation to the prevention of the formation of acne scars has not been fully studied. When choosing a method of therapy in patients with formed scars and an ongoing inflammatory process, preference should be given to those methods that contribute to the relief of inflammation and at the same time allow to act on cicatricial deformities. For the correction of scars, the following methods are used: fractional needle RF therapy, laser fractional ablative technologies (hot modes ER:YAG, CO2 lasers 2940,10 600), laser fractional nonablative technologies (1540 nm, 1470, 1440, 1330, 2940 nm), Nd:YAG 1064 nm, ILP.

Full Text

Restricted Access

About the authors

A. M Talybova

Central State Medical Academy of Department for Presidential Affairs of the Russian Federation

A. G Stenko

Institute of Plastic Surgery and Cosmetology

L. S Kruglova

Central State Medical Academy of Department for Presidential Affairs of the Russian Federation

Email: kruglovals@mail.ru
Dr. Sci. (Med.), Professor, Head of the Department of Dermatovenerology and Cosmetology

References

  1. Nast A., Dreno B, Bettoll V., et al. European evidence-based (S3) guideline for the treatment of acne-update 2016-short version. J Eur Acad Dermatol Venereol. 2016;30:1261-68. doi: 10.1111/jdv.13776.
  2. Tan J., Kang S., Leyden J. Prevalence and risk factors of acne scarring among patients consulting dermatologists in the Unites States. J Drugs Dermatol. 2017;16:97-102
  3. Fabbrocini G., Annunziata M.C., DArco V, et al. Acne scars: pathogenesis, classification and treatment. Dermatol Res Pract. 2010;2010:893080. doi: 10.1155/2010/893080.
  4. Tan J.K., Tang J., Fung K., et al. Development and validation of a Scale for Acne Scar Severity (SCAR-S) of the face and trunk. J Cutan Med Surg. 2010;14:156-60.
  5. Tan J., Thiboutot D., Gollnick H., et al. Development of an atrophic acne scar risk assessment tool. J Eur Acad Dermatol Venereol. 2017;31(9):1547-54. doi: 10.1111/jdv.14325.
  6. Finlay AY, Torres V, Kang S, et al. Classification of acne scars is difficult even for acne experts. J Eur Acad Dermatol Venereol. 2013;27(3):391-93. doi: 10.1111/j.1468-3083.2012.04461.x.
  7. Chivot M., Pawin H., Beylot C., et al. Acne scars: epidemiology, physiopathology, clinical features and treatment. Ann Dermatol Venereol. 2006;133:813-24. doi: 10.1016/s0151-9638(06)71053-5.
  8. Dreno B., Tan J., Rivier M., et al. Adapalene 0,1%/ benzoyl peroxide 2,5% gel reduces the risk of atrophic scar formation in moderate inflammatory acne: a split-face randomized controlled trial. J Eur Acad Dermatol Venereol. 2017;31:737-42. doi: 10.1111/jdv.14026.
  9. Bettoli V, Borghi A., Zauli S., et al. Maintenance therapy for acne vulgaris: efficacy of a 12-month treatment with adapalene-benzoyl peroxide after oral isotretinoin and a review of the literature. Dermatol. 2013;227:97-102. doi: 10.1159/000350820.
  10. Patel C.K.N. Continuous-wave laser action on vibrational-rotational transitions of CO2. Phys Rev. 1964;136(5A):A1187-A93.
  11. Omi T, Numano K. The role of the CO(2) laser and fractional CO(2) laser in dermatology Laser Ther. 2014;23(1):49-60. Doi: 10.5978/ islsm.14-RE-01.
  12. Scrimali L., Lomeo G., Nolfo C., et al. Treatment of hypertrophic scars and keloids with a fractional CO2 laser: a personal experience. J Cosmet Laser Ther. 2010;12(5):218-21. doi: 10.3109/14764172.2010.514924.
  13. Manstein D., Herron G.S., Sink R.K., et al. Fractional photothermolysis: a new concept for cutaneous remodeling using microscopic patterns of thermal injury. Lasers Surg. Med. 2004;34(5):426-38. doi: 10.1002/lsm.20048.
  14. Tierney E.P, Kouba D.J., Hanke C.W. Review of fractional photothermolysis: treatment indications and efficacy. Dermatol Surg. 2009;35(10): 1445-61. doi: 10.1111/j.1524-4725.2009. 01258.x.
  15. Choudhary S., McLeod M., Meshkov L., Nouri K. Lasers in the treatment of acne scars. Expert Rev Dermatol. 2011;6(1):45-60.
  16. Ong M., Bashir S. Fractional laser resurfacing for acne scars: a review. Br J Dermatol. 2012;166(6):1160-69. doi: 10.1111/j.1365-2133.2012.10870.x.
  17. Cho S.B., Lee S.J., Cho S., et al. Nonablative 1550-nm erbium-glass and ablative 10 600-nm carbon dioxide fractional lasers for acne scars: a randomized split-face study with blinded response evaluation. J Eur Acad Dermatol Venereol. 2010;24(8):921-25. doi: 10.1111/j.1468-3083.2009.03551.x.
  18. Asilian A., Salimi E., Faghihi G., et al. Comparison of Q-Switched 1064-nm Nd: YAG laser and fractional CO2 laser efficacies on improvement of atrophic facial acne scar. J Res Med Sci. 2011;16:9.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies